|
Volumn 22, Issue 5, 2008, Pages 519-526
|
Determination of levonorgestrel in human plasma by liquid chromatography - Tandem mass spectrometry method: Application to a bioequivalence study of two formulations in healthy volunteers
|
Author keywords
Bioavailability; Bioequivalence; Levonorgestrel; Liquid chromatography tandem mass spectrometry; Pharmacokinetics
|
Indexed keywords
BIOCHEMISTRY;
HIGH PRESSURE LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
PLASMA (HUMAN);
QUALITY CONTROL;
BIOAVAILABILITY;
BIOEQUIVALENCE;
BIOEQUIVALENCE STUDY;
HEALTHY VOLUNTEERS;
HUMAN PLASMAS;
LC-MS-MS;
LEVONORGESTREL;
LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY;
LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY;
RUNNING TIME;
PARTICLE SIZE;
ACETIC ACID ETHYL ESTER;
HEXANE;
LEVONORGESTREL;
ACCURACY;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BIOEQUIVALENCE;
BLOOD SAMPLING;
CLINICAL TRIAL;
COLUMN CHROMATOGRAPHY;
CONCENTRATION PROCESS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG DOSAGE FORM COMPARISON;
DRUG ELIMINATION;
DRUG SELECTIVITY;
DRUG STRUCTURE;
ELECTROSPRAY MASS SPECTROMETRY;
FEMALE;
HUMAN;
HUMAN EXPERIMENT;
LIQUID CHROMATOGRAPHY;
MAXIMUM PLASMA CONCENTRATION;
MENSTRUAL IRREGULARITY;
NORMAL HUMAN;
QUALITY CONTROL;
QUANTITATIVE ANALYSIS;
RANDOMIZED CONTROLLED TRIAL;
SENSITIVITY ANALYSIS;
SINGLE DRUG DOSE;
STRUCTURE ANALYSIS;
TABLET FORMULATION;
TANDEM MASS SPECTROMETRY;
VALIDATION PROCESS;
|
EID: 44249122831
PISSN: 02693879
EISSN: 10990801
Source Type: Journal
DOI: 10.1002/bmc.963 Document Type: Article |
Times cited : (12)
|
References (11)
|